The efficacy of Obinutuzumab , zanubrutinib combined with pomalidomide and Venetoclax for the treatment of high-risk mutated Mantle Cell Lymphoma (MCL): A prospective, open-label, single-arm study
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Ping Yang, Jinjie Gao, Lan Luo, Weilong Zhang, Jing Wang, Hongmei Jing
Institutions: Peking University, Peking University Third Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108735295
Cites:
Cited by:
Related to: